These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10544589)

  • 1. [Choice of antibiotics in uterine tract infections--the pendulum shifts back. Pivmecillinam is going to take back its role as the first choice preparation].
    Ferry S; Burman LG
    Lakartidningen; 1999 Sep; 96(39):4216-9. PubMed ID: 10544589
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is new prescription of antibiotics after treatment with sulfonamide or pivmecillinam a validated method for assessment of treatment failure?].
    Høiby N; Tvede M; Johansen HK
    Ugeskr Laeger; 2002 Feb; 164(7):920-1. PubMed ID: 11881563
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is repeat antibiotic prescription following treatment with sulfonamide or pivmecillinam a valid method for assessment of therapeutic failure in urinary infection?].
    Høiby N
    Ugeskr Laeger; 2003 Nov; 165(45):4316-7. PubMed ID: 14635335
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prescriptions of a new antibiotic following treatment with sulfamethizole or pivmecillinam].
    Bjerrum L; Dessau RB; Hallas J
    Ugeskr Laeger; 2003 Sep; 165(39):3732-5. PubMed ID: 14558387
    [No Abstract]   [Full Text] [Related]  

  • 5. [Uncomplicated lower urinary tract infection: 3-day therapy is recommended!].
    Mölstad S; Burman LG; Ferry S
    Lakartidningen; 1999 Sep; 96(39):4212-4. PubMed ID: 10544588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Repeat antibiotic prescriptions following treatment with sulfonamide or pivmecillinam. A survey of prescriptions among women aged 15-50 years in the county of Nordjylland].
    Schønheyder HC; Thrane N; Sørensen HT
    Ugeskr Laeger; 2001 Dec; 164(1):43-6. PubMed ID: 11810796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sulfamethizole versus pivmecillinam in urinary tract infections].
    Frimodt-Møller N
    Ugeskr Laeger; 2003 Nov; 165(45):4317; author reply 4317-8. PubMed ID: 14635336
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.
    Ferry SA; Holm SE; Stenlund H; Lundholm R; Monsen TJ
    Scand J Prim Health Care; 2007 Mar; 25(1):49-57. PubMed ID: 17354160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections - a randomized, double-blinded, placebo-controlled clinical trial study protocol.
    Jansåker F; Frimodt-Møller N; Bjerrum L; Dahl Knudsen J
    BMC Infect Dis; 2016 Dec; 16(1):727. PubMed ID: 27905884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivmecillinam plus pivampicillin in complicated urinary tract infection. Double-blind comparison of the combination pivmecillinam/pivampicillin and pivmecillinam alone in patients with urinary tract infection.
    Frimodt-Møller C; Vejlsgaard R
    J Int Med Res; 1981; 9(4):283-7. PubMed ID: 6266897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of pivmecillinam hydrochloride in lower urinary tract infections in pregnant women. Apropos of 44 cases].
    Henrion R; Vige P
    Rev Fr Gynecol Obstet; 1987 Dec; 82(12):761-4. PubMed ID: 3324273
    [No Abstract]   [Full Text] [Related]  

  • 12. General practice studies with combined pivampicillin/pivmecillinam (Miraxid).
    Moorhouse EC; Hickey MP; O'Hanrahan MT; Clarke PC
    Ir Med J; 1985 Nov; 78(11):314-7. PubMed ID: 3878343
    [No Abstract]   [Full Text] [Related]  

  • 13. Pivmecillinam in the treatment of urinary tract infections.
    Nicolle LE
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():35-9; discussion 63-5. PubMed ID: 11051622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment duration of pivmecillinam in men, non-pregnant and pregnant women for community-acquired urinary tract infections caused by Escherichia coli: a retrospective Danish cohort study.
    Boel JB; Jansåker F; Hertz FB; Hansen KH; Thønnings S; Frimodt-Møller N; Knudsen JD
    J Antimicrob Chemother; 2019 Sep; 74(9):2767-2773. PubMed ID: 31098630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral antibiotic treatment of urinary tract infections in children].
    Klingenberg C; Småbrekke L; Døllner H; Simonsen GS
    Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1342-4. PubMed ID: 19561661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Staph saprophyticus urinary tract infection. Spontaneous remission is rare but pivmecillinam is effective].
    Burman LG; Ahlmén J; Calmenius C; Ferry S; Johnson B
    Lakartidningen; 1993 Feb; 90(6):481-4. PubMed ID: 8437450
    [No Abstract]   [Full Text] [Related]  

  • 17. Short treatment regimen of lower urinary tract infections by pivmecillinam.
    Van Poppel H; Boeckx G; Broeckman J; Doupagne M; Opsomer RJ
    Acta Urol Belg; 1987; 55(3):479-84. PubMed ID: 3661328
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of acute urinary infections. Comparison between pivmecillinam for 3 days and sulfamethizole therapy for 6 days].
    Bitsch M; Hansen PH; Pagh J
    Ugeskr Laeger; 1985 Apr; 147(17):1392-5. PubMed ID: 4002410
    [No Abstract]   [Full Text] [Related]  

  • 19. A fixed combination of pivmecillinam and pivampicillin in complicated urinary tract infections. Double-blind comparison with pivmecillinam alone in hospitalized patients.
    Scand J Infect Dis; 1983; 15(2):195-9. PubMed ID: 6308755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general practice evaluation of pivmecillinam given twice daily as a treatment for acute urinary tract infection.
    Skinner JL; Venables TL; Sheldon MG
    Pharmatherapeutica; 1984; 4(1):25-31. PubMed ID: 6504945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.